U.S. stocks were lower, with the Nasdaq Composite falling more than 400 points on Friday.Shares of RH (NYSE:RH) rose sharply during Friday's session after the company reported better-than-expected third-quarter sales results.RH reported quarterly earnings of $1.71 per share, which missed the analyst estimate of $2.16 by 20.87%, according to data from Benzinga Pro. Quarterly revenue came in at $883.81 million, which beat the Street estimate of $883.69 million.RH shares jumped 5.8% to $162.14 on Friday.Here a ...

Cannabis stocks haven't moved like this in years, and it took a rare one-two punch to jolt the sector back to life: a Washington Post scoop hinting that President Donald Trump wants to reclassify marijuana into Schedule III — and a Tilray Brands Inc (NASDAQ:TLRY) vape launch so successful it broke the internal math of the company's own product mix. Track TLRY stock here.For an industry that's spent half a decade stuck in existential purgatory, this is what a revival looks like.Read Also: Tilray, Canopy And ...

Cannabis stocks haven't moved like this in years, and it took a rare one-two punch to jolt the sector back to life: a Washington Post scoop hinting that President Donald Trump wants to reclassify marijuana into Schedule III — and a Tilray Brands Inc (NASDAQ:TLRY) vape launch so successful it broke the internal math of the company's own product mix. Track TLRY stock here.For an industry that's spent half a decade stuck in existential purgatory, this is what a revival looks like.Read Also: Tilray, Canopy And ...

Core Viewpoint - Tilray Brands (NASDAQ: TLRY) stock experienced a significant increase of 25% in the morning, attributed to President Trump's potential executive order to reclassify marijuana as a Schedule III drug, which could ease regulations surrounding the industry [1][3]. Regulatory Changes - President Trump is expected to issue an executive order to reclassify marijuana as a Schedule III drug as early as January, which would reduce the regulatory burden on marijuana businesses, aligning them more closely with prescription painkillers rather than more strictly regulated substances like heroin [3][4]. - This reclassification would not legalize marijuana outright but would facilitate banking services for marijuana companies and lessen their tax obligations, allowing states to regulate marijuana use from a federal perspective [4]. Impact on Tilray Brands - The easing of regulations is likely to increase legal demand for marijuana, potentially boosting sales and profits for Tilray [5]. - Despite the potential benefits, Tilray has not been profitable since 2018, even with marijuana being legal in Canada, raising concerns about whether U.S. reclassification will significantly change its financial outlook [6]. Investment Considerations - Investors are advised to consider the implications of the upcoming regulatory changes before investing in Tilray Brands, as the expected reclassification is not a full legalization of marijuana [7]. - Analysts have identified other stocks that may offer better investment opportunities compared to Tilray Brands, suggesting caution for potential investors [8].

Core Insights - Tilray Brands Inc (NASDAQ:TLRY) stock has surged by 29% to $10.87 following reports that U.S. President Donald Trump intends to reclassify marijuana and ease restrictions significantly [1] - The stock is trading at its highest levels since mid-November, breaking above the descending 20-day moving average, and could mark its largest daily percentage gain since a 60.9% increase in September [1] Options Activity - Options trading for Tilray has seen a significant uptick, with 49,000 calls and 18,000 puts exchanged, which is six times the typical volume for this time [2] - The most popular options include the weekly 12/12 11-strike put and the 12-strike call, with new positions being opened in both [2] Short Interest - Short interest in Tilray has decreased by 88.8% over the last two weeks, although it still represents 9.6% of the stock's available float [3] - It would take nearly two days for short sellers to cover their positions based on TLRY's average trading volume [3]

Core Viewpoint - Cannabis stocks experienced a significant surge, with Tilray Brands rising over 32%, Canopy Growth increasing over 23%, SNDL up over 19%, Aurora Cannabis rising over 11%, and Cronos Group gaining over 5% due to reports that President Donald Trump is considering reclassifying cannabis to a lower risk category [1] Group 1 - Tilray Brands (TLRY.US) saw an increase of over 32% [1] - Canopy Growth (CGC.US) rose by more than 23% [1] - SNDL (SNDL.US) increased by over 19% [1] - Aurora Cannabis (ACB.US) experienced a rise of over 11% [1] - Cronos Group (CRON.US) gained over 5% [1] Group 2 - Reports indicate that President Trump is expected to push for the reclassification of cannabis as a "lower risk drug" [1] - Trump is considering moving cannabis from Schedule I, which indicates no medical use and high abuse potential, to Schedule III, which includes substances with lower dependency and addiction potential [1]

智通财经APP获悉，周五，大麻股集体狂飙，Tilray Brands(TLRY.US)大涨超32%，canopy growth(CGC.US)涨超23%，SNDL(SNDL.US)涨超19%，极光大麻(ACB.US)涨超11%，cronos group(CRON.US)涨超5%。消息面上，多家美国当地媒体报道称，美国总统唐纳德.特朗普预计将推动把 大麻重新归类为"危害性较低的药物"。根据媒体报道，特朗普正在考虑将大麻从"附表I"(Schedule I) ——该类别表示无医疗用途且具有高滥用潜力——大幅度调整至"附表III"——这是一类依赖性与成瘾性 潜力较低的物质类别。 ...

Core Insights - The reclassification of the drug is expected to alleviate tax burdens on cannabis companies [1] Industry Impact - Cannabis companies will benefit from reduced tax liabilities due to the reclassification of the drug [1]

The stock prices of major cannabis companies like Tilray Brands (NASDAQ:TLRY) and Canopy Growth (NASDAQ:CGC) skyrocketed 34.88% and 27.46%, respectively, in premarket trading on Friday, following reports of President Donald Trump‘s plans to relax federal regulations on marijuana. Meanwhile, Aurora Cannabis Inc. (NASDAQ:ACB) surged 20%, Cronos Group Inc. (NASDAQ:CRON) gained 19% and Organigram Global Inc. (NASDAQ:OGI), and SNDL Inc. (NASDAQ:SNDL) rose 12% and 34.7% respectively. Reclassification Of Cannabis ...

Market Analysis by covering: Tilray Inc. Read 's Market Analysis on Investing.com ...